Sign In
Buy RHHBY
$49.06
-0.130 (-0.264%)
At Close: Jun 03, 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support U
Basel, 13 May 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced today stati
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
12:36pm, Monday, 12'th May 2025
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
12:30pm, Monday, 12'th May 2025
President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up t
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
10:30am, Monday, 12'th May 2025
An investment of up to $550 million by 2030 will establish the Indianapolis site as a hub for manufacturing of Roche's continuous glucose monitoring solution. Expansion will create hundreds of jobs wh
Roche to invest $700 million in new drug manufacturing facility in North Carolina
09:05am, Monday, 12'th May 2025
Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly Springs, North Carolina.
Roche and Genentech Announce New North Carolina Manufacturing Facility
08:30am, Monday, 12'th May 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square foot s
Zealand Pharma announces closing of collaboration and license agreement with Roche
12:25am, Friday, 09'th May 2025
Company announcement – No. 12 / 2025 Zealand Pharma announces closing of collaboration and license agreement with Roche Copenhagen, Denmark, May 9, 2025 – Zealand Pharma A/S ("the Company" or “Z
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
01:00am, Tuesday, 06'th May 2025
Basel, 06 May 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of its Elecsys® PRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in patients
Hanover Insurance CEO on tariffs: Situation is manageable due to cost visibility
03:14pm, Friday, 02'nd May 2025
Jack Roche, The Hanover Group CEO, joins 'The Exchange' to discuss the company's quarterly earnings results, how tariffs are impacting Roche's business, what's next for insurance premiums, and much mo
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
01:19am, Friday, 02'nd May 2025
Roche and Zealand Pharma in March struck a deal worth up to $5.3 billion to co-develop and co-commercialize amylin analog petrelintide as a potentially "next generation" weight loss drug. Executives a
Roche Holding AG (RHHBY) is a Great Momentum Stock: Should You Buy?
01:00pm, Thursday, 01'st May 2025
Does Roche Holding AG (RHHBY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Roche Holding (RHHBY) Stock Outpacing Its Medical Peers This Year?
10:46am, Wednesday, 30'th Apr 2025
Here is how Roche Holding AG (RHHBY) and argenex SE (ARGX) have performed compared to their sector so far this year.
Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Blood-Based Biomarker Market - A Global and Regional Analysis: Focus on Disease, Application, and Country-Level Analysis, 2025-2035" report has been add
CHMP recommends EU label update for Roche's Phesgo to allow administration outside of clinical settings
01:00am, Wednesday, 30'th Apr 2025
Basel, 30 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recom
